首页> 外文期刊>Clinical nuclear medicine >Reduction of glucose metabolism in basal ganglia diagnosed with FDG-PET scan: a neuroacanthocytosis case.
【24h】

Reduction of glucose metabolism in basal ganglia diagnosed with FDG-PET scan: a neuroacanthocytosis case.

机译:FDG-PET扫描诊断为基底神经节的葡萄糖代谢降低:神经棘皮细胞增多症病例。

获取原文
获取原文并翻译 | 示例
           

摘要

Neuroacanthocytosis is a rare movement disorder marked by progressive muscle weakness and atrophy, progressive cognitive loss, chorea, and acanthocytosis. Neuroacanthocytosis is typically an inherited autosomal recessive disorder and is more common in males than in females. The disorder is due to degeneration of the basal ganglia by loss of neurons. Symptoms typically occur between 25 and 45 years of age. FDG PET has been increasingly used for detection of neurologic disorders, such as dementia, epilepsy, and movement disorders. We present an interesting case of neuroacanthocytosis with FDG-PET images showing decreased FDG uptake in the basal ganglia.
机译:神经棘皮细胞增多症是一种罕见的运动障碍,其特征是进行性肌肉无力和萎缩,进行性认知丧失,舞蹈症和棘皮细胞缺乏症。神经棘皮细胞增多症通常是一种遗传性常染色体隐性遗传疾病,男性多于女性。该疾病是由于神经元的丧失导致基底神经节的退化。症状通常发生在25至45岁之间。 FDG PET已越来越多地用于检测神经系统疾病,例如痴呆,癫痫和运动障碍。我们用FDG-PET图像显示神经棘皮细胞增多症的有趣案例,显示基底神经节中FDG摄取减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号